|
|
Volumn 138, Issue 4, 2010, Pages 1622-1624
|
|
Predicting Response to Pegylated Interferon/Ribavirin-Based Therapy in Genotype 1 Chronic Hepatitis C Patients: Results of 3 Independent Genome-Wide Association Studies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOTRANSFERASE;
INTERFERON;
INTERFERON LAMBDA 3;
INTERLEUKIN 10;
INTERLEUKIN 28;
INTERLEUKIN 28A;
INTERLEUKIN 28B;
INTERLEUKIN 29;
JANUS KINASE;
PEGINTERFERON ALPHA;
RIBAVIRIN;
STAT PROTEIN;
UNCLASSIFIED DRUG;
AFRICA;
AFRICAN AMERICAN;
AMINOTRANSFERASE BLOOD LEVEL;
ANTIVIRAL THERAPY;
ARTICLE;
AUSTRALIA;
CAUCASIAN;
COST OF ILLNESS;
GENE EXPRESSION REGULATION;
GENE FREQUENCY;
GENE LINKAGE DISEQUILIBRIUM;
GENE MAPPING;
GENETIC ASSOCIATION;
GENETIC MARKER;
GENETIC VARIABILITY;
GENOME ANALYSIS;
GENOME WIDE ASSOCIATION;
GENOTYPE;
HEPATITIS C;
HETEROZYGOTE;
HOMOZYGOTE;
HUMAN;
JAPANESE;
LIVER FIBROSIS;
PREDICTION;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
THROMBOCYTE COUNT;
TREATMENT DURATION;
TREATMENT RESPONSE;
VIRUS LOAD;
|
|
EID: 77949855620
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/j.gastro.2010.02.023 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
